STING1 and neoplasm: In a mouse colorectal cancer model, the STING agonist diABZI in combination with the IDO inhibitor 1-MT significantly inhibited tumor growth, promoting the recruitment of CTLs and inhibiting the infiltration of MDSCs (75).